SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001104659-23-027696
Filing Date
2023-03-02
Accepted
2023-03-02 08:42:52
Documents
4

Document Format Files

Seq Description Document Type Size
1 PRER14A tm231898-3_pre14a.htm PRER14A 409494
2 GRAPHIC lg_rubiustherapeut-4c.jpg GRAPHIC 84840
3 GRAPHIC px_meeting-bw.jpg GRAPHIC 669157
4 GRAPHIC px_scanto-bw.jpg GRAPHIC 945418
  Complete submission text file 0001104659-23-027696.txt   2547801
Mailing Address C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035
Business Address C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-38586 | Film No.: 23696548
SIC: 2836 Biological Products, (No Diagnostic Substances)